| D01145 | |
| D number | D01145 |
| Classification | Drug |
| Name | Azelnidipine (JP17/INN); Azelnidipine tablets (JP17); Calblock (TN) |
| Component | - |
| Formula | C33H34N4O6 |
| Exact mass | 582.2478 |
| Mol weight | 582.6463 |
| Structural formula |  |
| Sequence | - |
| Sequence type | - |
| Source | - |
| Upper DGroup | Cardiovascular agent DG01928 Dihydropyridine calcium channel blocker Other DG01575 Calcium channel blocker DG01496 Calcium channel L type blocker Cyp substrate DG01633 CYP3A substrate |
| Remark | Therapeutic category: 2149 |
| Activity | - |
| Disease | - |
| Comment | Dihydropyridine derivative |
| Target | CACNA1C [HSA:775] [KO:K04850]; CACNA1D [HSA:776] [KO:K04851]; CACNA1F [HSA:778] [KO:K04853]; CACNA1S [HSA:779] [KO:K04857] |
| Metabolism | Enzyme: CYP3A4 [HSA:1576] |
| Interaction | Transporter inhibition: ABCB1 [HSA:5243] |
| Other DBs | CAS: 123524-52-7 PubChem: 7848208 ChEBI: 31247 ChEMBL: CHEMBL1275868 LigandBox: D01145 NIKKAJI: J429.875F |
| KCF data | - |